Proteogenomic analysis of 5,411 plasma proteins in sickle cell disease patients
There are few therapeutic options to treat patients with sickle cell disease (SCD), a blood disorder caused by mutations in the β-globin gene that affects > 7M individuals worldwide. Combining human genetics and high-throughput proteomics can help identify new drug targets. Here, we present results from a proteogenomic analysis of the plasma proteome in SCD patients. We measured the levels of 5,411 plasma proteins and tested their associations with common genetic variation in 343 SCD patients. After conditional analyses, we identified 560 protein quantitative trait loci (pQTL), including 58 (10%) that are novel. Many of these pQTL are not specific to SCD patients and associate with clinically relevant traits in non-SCD African Americans from the Million Veteran Program (e.g., hemoglobin concentration, triglycerides). The effect sizes of the pQTL are largely concordant between SCD and non-SCD individuals, although we found examples (e.g., APOL1, haptoglobin) with evidence of heterogeneity that suggests an interaction between the plasma proteome and the SCD genotype. Finally, we combine pQTL and genome-wide association study results for fetal hemoglobin (HbF) in a Mendelian randomization analysis to prioritize four proteins that may increase HbF production (ENPP5, LBP, PTX3, ZP3). We have combined high-throughput DNA genotyping and plasma proteome profiling to confirm known and identify new genetic variants associated with protein level variation in SCD. Our results provide an opportunity to prioritize novel SCD drug targets that are informed by human genetics.
Authors
- Ken Sin Lo (ORCID: https://orcid.org/0000-0003-1904-2625)
- Cristian Groza (ORCID: https://orcid.org/0000-0001-6624-5404)
- Pablo Bartolucci (ORCID: https://orcid.org/0000-0002-7007-1344)
- Arnaud Chignon (ORCID: https://orcid.org/0009-0008-2344-2254)
- Guillaume Lettre (ORCID: https://orcid.org/0000-0002-7740-3399)
- Vanessa Bellegarde (ORCID: https://orcid.org/0009-0002-8963-348X)
Institutions
- Université Paris-Est Créteil (FR)
- Montreal Heart Institute (CA)
- Université de Montréal (CA)
Publication Details
- Journal
- PLoS Genetics
- Published
- 2026-11-16
- DOI
- https://doi.org/10.1371/journal.pgen.1012377
- Primary Topic
- Hemoglobinopathies and Related Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- McGill University
- Banting Research Foundation
- Canada Research Chairs
- Alliance de recherche numérique du Canada
- Canadian Institutes of Health Research
- Fonds de recherche du Québec – Nature et technologies
- Institute of Genetics